
Dr Sarah Kidd
Adjunct Senior Lecturer
School of Biological Sciences
Faculty of Sciences, Engineering and Technology
Sarah Kidd is Head of the National Mycology Reference Centre at SA Pathology, Adelaide, as well as adjunct senior lecturer at the University of Adelaide. She completed a Bachelor of Medical Science with Honours, and a PhD in Medicine, both at the University of Sydney. She holds Fellowships of the Australian Society for Microbiology, and of the European Confederation of Medical Mycology. She has undertaken postdoctoral training and research in medical mycology at the University of British Columbia, Vancouver, Canada, and at Monash University at The Alfred Hospital, Melbourne. Research interests include the epidemiology, phylogeny, and antifungal susceptibilities of fungi, in particular Aspergillus and Cryptococcus species.
Please note correct email address: SARAH.KIDD@SA.GOV.AU
-
Appointments
Date Position Institution name 2012 - ongoing Adjunct Senior Lecturer University of Adelaide 2011 - ongoing Head, National Mycology Reference Centre SA Pathology 2006 - 2010 Postdoctoral Research Scientist Monash University, Melbourne 2003 - 2006 Postdoctoral Research Scientist University of British Columbia -
Awards and Achievements
Date Type Title Institution Name Country Amount 2023 Fellowship Fellow of the European Confederation of Medical Mycology ECMM Australia - 2018 Fellowship Fellowship of the Australian Society for Microbiology Australian Society for Microbiology Australia - -
Education
Date Institution name Country Title 2000 - 2003 University of Sydney Australia PhD 1996 - 1999 University of Sydney Australia Bachelor of Medical Science (Hons.) -
Postgraduate Training
Date Title Institution Country 2006 - 2010 Research Fellow Monash University, Alfred Hospital Australia 2003 - 2006 Postdoctoral Research Fellow University of British Columbia Canada -
Research Interests
-
Journals
Year Citation 2023 Tio, S. Y., Chen, S. C. A., Hamilton, K., Heath, C. H., Pradhan, A., Morris, A. J., . . . Slavin, M. A. (2023). Invasive aspergillosis in adult patients in Australia and New Zealand: 2017–2020. The Lancet Regional Health - Western Pacific, 40, 100888.
Scopus12023 Jenks, J. D., White, P. L., Kidd, S. E., Goshia, T., Fraley, S. I., Hoenigl, M., & Thompson, G. R. (2023). An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections. Expert Review of Molecular Diagnostics, 18 pages.
2023 Kidd, S. E., Abdolrasouli, A., & Hagen, F. (2023). Fungal Nomenclature: Managing Change is the Name of the Game. OPEN FORUM INFECTIOUS DISEASES, 10(1), 15 pages.
Europe PMC82023 Kidd, S. E., Abdolrasouli, A., & Hagen, F. (2023). Reply to "re: Fungal Nomenclature: Managing Change Is the Name of the Game". Open Forum Infectious Diseases, 10(8), 1 page.
2023 O’hern, J. A., Koenen, A., Janson, S., Hajkowicz, K. M., Robertson, I. K., Kidd, S. E., . . . Ralph, A. P. (2023). Epidemiology, management and outcomes of Cryptococcus gattii infections: A 22-year cohort. PLoS Neglected Tropical Diseases, 17(3), e0011162.
Scopus12022 Lamont-Friedrich, S. J., Kidd, S. E., Giles, C., Griesser, H. J., & Coad, B. R. (2022). Candida auris susceptibility on surfaces coated with the antifungal drug caspofungin. Medical Mycology, 60(1), 4 pages.
WoS12022 Kidd, S. E., Halliday, C. L., Haremza, E., Gardam, D. J., Chen, S. C. A., & Elvy, J. A. (2022). Attitudes of Australasian Clinicians and Laboratory Staff to Changing Fungal Nomenclature: Has Mycological Correctness Really Gone Mad?. Microbiology Spectrum, 10(1), 6 pages.
Scopus4 WoS6 Europe PMC42022 Kidd, S. E., & Weldhagen, G. F. (2022). Diagnosis of dermatophytes: from microscopy to direct PCR. Microbiology Australia, 43(1), 9-13.
Scopus5 WoS52022 Crawford, L. C., Kidd, S. E., Anninos, T. M., Turra, M., & Weldhagen, G. F. (2022). Candida auris PCR for high-throughput infection control screening. Medical Mycology, 60(8), 6 pages.
Scopus3 WoS3 Europe PMC22022 Halliday, C. L., Weeks, K., Farac, K., Alexiou, H., Green, W., Lopez, R., . . . Kidd, S. E. (2022). Evaluation of a custom Sensititre YeastOne plate for susceptibility testing of isavuconazole and other antifungals against clinically relevant yeast and mould species in three Australian diagnostic mycology laboratories. Pathology, 54(7), 922-927.
Scopus1 Europe PMC12021 Kay, A., Boland, L., Kidd, S. E., Beatty, J. A., Talbot, J. J., & Barrs, V. R. (2021). Complete clinical response to combined antifungal therapy in two cats with invasive fungal rhinosinusitis caused by cryptic Aspergillus species in section Fumigati. Medical Mycology Case Reports, 34, 13-17.
Scopus3 WoS3 Europe PMC32021 Teo, T. S. P., Crawford, L. C., Pilch, W. T., Carney, B., Solanki, N., Kidd, S. E., & Warner, M. S. (2021). Mycetoma caused by Microsporum canis in a patient with renal transplant: A case report and review of the literature. Transplant Infectious Disease, 23(3), 6 pages.
Scopus2 WoS17 Europe PMC12021 Kidd, S. E., Halliday, C. L., McMullan, B., Chen, S. C. A., & Elvy, J. (2021). New names for fungi of medical importance: Can we have our cake and eat it too?. Journal of Clinical Microbiology, 59(3), 2 pages.
Scopus11 WoS12 Europe PMC52021 Keighley, C. L., Pope, A., Marriott, D. J. E., Chapman, B., Bak, N., Daveson, K., . . . Chen, S. C. A. (2021). Risk factors for candidaemia: A prospective multi-centre case-control study. Mycoses, 64(3), 257-263.
Scopus17 WoS15 Europe PMC112021 Kidd, S. E., Crawford, L. C., & Halliday, C. L. (2021). Antifungal Susceptibility Testing and Identification. Infectious Disease Clinics of North America, 35(2), 313-339.
Scopus11 WoS10 Europe PMC62021 Khanina, A., Tio, S. Y., Ananda-Rajah, M. R., Kidd, S. E., Williams, E., Chee, L., . . . Thursky, K. A. (2021). Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021. Internal Medicine Journal, 51(S7), 18-36.
Scopus12 WoS12 Europe PMC32020 Kidd, S. E., Chen, S. C. A., Meyer, W., & Halliday, C. L. (2020). A New Age in Molecular Diagnostics for Invasive Fungal Disease: Are We Ready?. Frontiers in Microbiology, 10, 20 pages.
Scopus88 WoS80 Europe PMC522020 Ross, I. L., Weldhagen, G. F., & Kidd, S. E. (2020). Detection and identification of dermatophyte fungi in clinical samples using a commercial multiplex tandem PCR assay. Pathology, 52(4), 473-477.
Scopus12 WoS9 Europe PMC32020 Davidson, N., Campbell, K., Foroughi, F., Tayal, V., Lynar, S., Crawford, L. C., . . . Meumann, E. M. (2020). Disseminated Saksenaea infection in an immunocompromised host associated with a good clinical outcome: a case report and review of the literature. BMC Infectious Diseases, 20(1), 5 pages.
2019 Espinel-Ingroff, A., Turnidge, J., Alastruey-Izquierdo, A., Botterel, F., Canton, E., Castro, C., . . . Tejada, M. (2019). Method-dependent epidemiological cutoff values for detection of triazole resistance in Candida and Aspergillus species for the Sensititre Yeastone colorimetric broth and etest agar diffusion methods. Antimicrobial Agents and Chemotherapy, 63(1), 15 pages.
Scopus51 WoS44 Europe PMC272019 Marshall, A. C., Kidd, S. E., Lamont-Friedrich, S. J., Arentz, G., Hoffmann, P., Coad, B. R., & Bruning, J. B. (2019). Structure, mechanism, and inhibition of aspergillus fumigatus thioredoxin reductase. Antimicrobial Agents and Chemotherapy, 63(3), 1-15.
Scopus26 WoS25 Europe PMC112019 Thomson, J., Trott, D. J., Malik, R., Galgut, B., McAllister, M. M., Nimmo, J., . . . Kidd, S. E. (2019). An atypical cause of sporotrichosis in a cat. Medical Mycology Case Reports, 23, 72-76.
Scopus17 WoS16 Europe PMC92019 Keighley, C., Chen, S. C. A., Marriott, D., Pope, A., Chapman, B., Kennedy, K., . . . Slavin, M. A. (2019). Candidaemia and a risk predictive model for overall mortality: A prospective multicentre study. BMC Infectious Diseases, 19(1), 10 pages.
Scopus30 WoS24 Europe PMC162019 Hossain, M. A., Biva, I. J., Kidd, S. E., Whittle, J. D., Griesser, H. J., & Coad, B. R. (2019). Antifungal activity in compounds from the Australian desert plant Eremophila alternifolia with potency against Cryptococcus spp. Antibiotics, 8(2), 34-1-34-12.
Scopus6 WoS6 Europe PMC32019 Chew, S. M., Sweeney, N., Kidd, S. E., & Reed, C. (2019). Candida auris arriving on our shores: an Australian microbiology laboratory's experience. Pathology, 51(4), 431-433.
Scopus6 WoS5 Europe PMC22019 New, D., Beukers, A. G., Kidd, S. E., Merritt, A. J., Weeks, K., Van Hal, S. J., & Arthur, I. (2019). Identification of multiple species and subpopulations among Australian clinical Sporothrix isolates using whole genome sequencing. Medical Mycology, 57(7), 905-908.
Scopus14 WoS12 Europe PMC82019 Meyer, W., Arthur, I., Ellis, D., Kan, A., Kidd, S., Maszewska, K., & Weeks, K. (2019). Australian medical mycology culture collections: Fundamental resources for mycological diagnosis and research. Microbiology Australia, 40(3), 130-134.
2019 Ong, C. W., Chen, S. C. A., Clark, J. E., Halliday, C. L., Kidd, S. E., Marriott, D. J., . . . Heath, C. H. (2019). Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases. Internal Medicine Journal, 49(10), 1229-1243.
Scopus32 WoS24 Europe PMC112019 Biswas, C., Marcelino, V., Van Hal, S., Halliday, C., Martinez, E., Wang, Q., . . . Chen, S. (2019). Corrigendum: Whole genome sequencing of australian candida glabrata isolates reveals genetic diversity and novel sequence types (Front. Microbiol., (2018), 9, (2946), 10.3389/fmicb.2018.02946). Frontiers in Microbiology, 10(SEP), 2218.
2019 Talbot, J. J., Frisvad, J. C., Meis, J. F., Hagen, F., Verweij, P. E., Hibbs, D. E., . . . Houbraken, J. (2019). Cyp51A mutations, extrolite profiles, and antifungal susceptibility in clinical and environmental isolates of the aspergillus viridinutans species complex. Antimicrobial Agents and Chemotherapy, 63(11), 13 pages.
Scopus15 WoS16 Europe PMC82019 Pérez-Hansen, A., Lass-Flörl, C., Lackner, M., Aigner, M., Alastruey-Izquierdo, A., Arikan-Akdagli, S., . . . Willinger, B. (2019). Antifungal susceptibility profiles of rare ascomycetous yeasts. Journal of Antimicrobial Chemotherapy, 74(9), 2649-2656.
Scopus17 WoS17 Europe PMC122018 Bennett, P. F., Talbot, J. J., Martin, P., Kidd, S. E., Makara, M., & Barrs, V. R. (2018). Long term survival of a dog with disseminated Aspergillus deflectus infection without definitive treatment. Medical Mycology Case Reports, 22, 1-3.
Scopus4 WoS4 Europe PMC22018 Marinelli, T., Kidd, S., Shaw, D., & Rowe, E. (2018). Aspergillus fumigatus endocarditis in an indigenous Australian male without classic risk factors. Medical Mycology Case Reports, 22, 61-64.
Scopus3 WoS3 Europe PMC32018 Kidd, S. E., Halliday, C. L., Morris, A. J., & Chen, S. C. A. (2018). Antifungal susceptibility testing in Australasian clinical laboratories: we must improve our performance. Pathology, 50(3), 257-260.
Scopus6 WoS62018 Espinel-Ingroff, A., Turnidge, J., Alastruey-Izquierdo, A., Dannaoui, E., Garcia-Effron, G., Guinea, J., . . . Tortorano, A. M. (2018). Posaconazole MIC distributions for aspergillus fumigatus species complex by four methods: Impact of cyp51a mutations on estimation of epidemiological cutoff values. Antimicrobial Agents and Chemotherapy, 62(4), 11 pages.
Scopus31 WoS26 Europe PMC122018 Biswas, C., Marcelino, V. R., Van Hal, S., Halliday, C., Martinez, E., Wang, Q., . . . Chen, S. C. A. (2018). Whole Genome Sequencing of Australian Candida glabrata Isolates Reveals Genetic Diversity and Novel Sequence Types. Frontiers in Microbiology, 9, 12 pages.
Scopus26 WoS24 Europe PMC232017 Talbott, J. J., Houbraken, J., Frisvad, J. C., Samson, R. A., Kidd, S., Pitt, J., . . . Barrs, V. R. (2017). Discovery of Aspergillus frankstonensis sp. nov. during
environmental sampling for animal and human fungal pathogens. PLoS ONE, 12(8), e0181660-1-e0181660-17.
Scopus13 WoS12 Europe PMC82017 Espinel-Ingroff, A., Abreu, D. P. B., Almeida-Paes, R., Brilhante, R. S. N., Chakrabarti, A., Chowdhary, A., . . . Turnidge, J. (2017). Multicenter, International Study of MIC/ MEC Distributions for definition of epidemiological cutoff values for sporothrix species identified by molecular methods. Antimicrobial Agents and Chemotherapy, 61(10), e01057-17-1-e01057-17-8.
Scopus69 WoS51 Europe PMC472017 Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., . . . Chen, S. (2017). Changing epidemiology of candidaemia in Australia.. The Journal of antimicrobial chemotherapy, 72(4), 1103-1108.
Scopus113 WoS96 Europe PMC552017 Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., . . . Chen, S. (2017). Erratum: Changing epidemiology of candidaemia in Australia [J Antimicrob Chemother, 72, (2017) (1103-1108)] DOI:10.1093/jac/dkw422. Journal of Antimicrobial Chemotherapy, 72(4), 1270.
Scopus28 WoS36 Europe PMC272016 Lategan, M. J., Klare, W., Kidd, S., Hose, G. C., & Nevalainen, H. (2016). The unicellular fungal tool RhoTox for risk assessments in groundwater systems. Ecotoxicology and Environmental Safety, 132, 18-25.
Scopus6 WoS6 Europe PMC32016 McGuinness, S., Boyd, R., Kidd, S., McLeod, C., Krause, V., & Ralph, A. (2016). Epidemiological investigation of an outbreak of cutaneous sporotrichosis, Northern Territory, Australia. BMC Infectious Diseases, 16(1), 1-7.
Scopus26 WoS21 Europe PMC132016 Morton, C. O., White, P. L., Barnes, R. A., Klingspor, L., Cuenca-Estrella, M., Lagrou, K., . . . Loeffler, J. (2016). Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus ?. Medical Mycology, 55(4), myw093.
Scopus31 WoS27 Europe PMC192016 Morris, A. J., Arthur, I. H., Kidd, S. E., Halliday, C. L., Meyer, W., Robson, J. M., . . . Haremza, E. (2016). Mycological testing of clinical samples in Australasian pathology laboratories: wide diversity and room for improvement. Pathology, 48(6), 531-534.
Scopus5 WoS5 Europe PMC22016 Kennedy, K. J., Daveson, K., Slavin, M. A., van Hal, S. J., Sorrell, T. C., Lee, A., . . . Chen, S. C. A. (2016). Mucormycosis in Australia: Contemporary epidemiology and outcomes. Clinical Microbiology and Infection, 22(9), 775-781.
Scopus73 WoS64 Europe PMC412016 Espinel-Ingroff, A., Colombo, A., Cordoba, S., Dufresne, P., Fuller, J., Ghannoum, M., . . . Turnidge, J. (2016). International evaluation of MIC distributions and epidemiological cutoff value (ECV) definitions for Fusarium species identified by molecular methods for the CLSI broth microdilution method. Antimicrobial Agents and Chemotherapy, 60(2), 1079-1084.
Scopus106 WoS99 Europe PMC622016 Halliday, C., Chen, S., Kidd, S., van Hal, S., Chapman, B., Heath, C., . . . Slavin, M. (2016). Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations. International Journal of Antimicrobial Agents, 48(4), 453-458.
Scopus22 WoS22 Europe PMC92015 Slavin, M., van Hal, S., Sorrell, T., Lee, A., Marriott, D., Daveson, K., . . . Chambers, S. (2015). Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality. Clinical Microbiology and Infection, 21(5), 490.e1-490.e10.
Scopus121 WoS96 Europe PMC702015 Halliday, C. L., Kidd, S. E., Sorrell, T. C., & Chen, S. C. A. (2015). Molecular diagnostic methods for invasive fungal disease: the horizon draws nearer?. Pathology, 47(3), 257-269.
Scopus40 WoS33 Europe PMC232015 van der Linden, J. W. M., Arendrup, M. C., Warris, A., Lagrou, K., Pelloux, H., Hauser, P. M., . . . Verweij, P. E. (2015). Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. Emerging Infectious Diseases, 21(6), 1041-1044.
Scopus285 WoS260 Europe PMC1792015 Espinel-Ingroff, A., & Kidd, S. E. (2015). Current trends in the prevalence of Cryptococcus gattii in the United States and Canada. Infection and Drug Resistance, 8, 89-97.
Scopus41 WoS39 Europe PMC252015 Talbot, J. J., Kidd, S. E., Martin, P., Beatty, J. A., & Barrs, V. R. (2015). Azole resistance in canine and feline isolates of Aspergillus fumigatus. Comparative Immunology, Microbiology and Infectious Diseases, 42, 37-41.
Scopus15 WoS8 Europe PMC62015 Kidd, S. E., Goeman, E., Meis, J. F., Slavin, M. A., & Verweij, P. E. (2015). Multi-triazole-resistant Aspergillus fumigatus infections in Australia. Mycoses, 58(6), 350-355.
Scopus89 WoS79 Europe PMC602015 Gardiner, B. J., Simpson, I., Khuu, M. H., Kidd, S. E., Lo, C. H., & Jenkin, G. A. (2015). An unusual ulcer: A case of cutaneous mucormycosis caused by Rhizopus oryzae. Medical Mycology Case Reports, 7, 8-11.
Scopus4 WoS3 Europe PMC42015 Espinel-Ingroff, A., Chakrabarti, A., Chowdhary, A., Cordoba, S., Dannaoui, E., Dufresne, P., . . . Turnidge, J. (2015). Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales. Antimicrobial Agents and Chemotherapy, 59(3), 1745-1750.
Scopus87 WoS72 Europe PMC532015 Espinel-Ingroff, A., Alvarez-Fernandez, M., Cantón, E., Carver, P., Chen, S., Eschenauer, G., . . . Turnidge, J. (2015). Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method. Antimicrobial Agents and Chemotherapy, 59(11), 6725-6732.
Scopus55 WoS52 Europe PMC362015 Brischetto, A., Kidd, S., & Baird, R. (2015). Case report: First reported Australian case of Cladophilophora arxii: Features consistent with possible primary pulmonary chromoblastomycosis. American Journal of Tropical Medicine and Hygiene, 92(4), 791-793.
Scopus4 WoS5 Europe PMC32015 Khoury, S., Kidd, S., & Warren, L. (2015). Neonatal tinea corporis due to a novel strain of Trichophyton rubrum. Australasian Journal of Dermatology, 56(4), 311-312.
Scopus4 WoS3 Europe PMC32015 Kidd, S., Halliday, C., & Ellis, D. (2015). The role of clinical mycology reference laboratories. Microbiology Australia, 36(2), 64-66.
2014 Subedi, S., Kidd, S. E., Baird, R. W., Coatsworth, N., & Ralph, A. P. (2014). Case Report: Sporotrichosis from the northern territory of Australia. American Journal of Tropical Medicine and Hygiene, 91(6), 1263-1268.
Scopus6 WoS7 Europe PMC32014 Macesic, N., Fleming, S., Kidd, S., Madigan, V., Chean, R., Ritchie, D., & Slavin, M. (2014). Protothecosis in hematopoietic stem cell transplantation: Case report and review of previous cases. Transplant Infectious Disease, 16(3), 490-495.
Scopus18 WoS15 Europe PMC102014 Talbot, J. J., Johnson, L. R., Martin, P., Beatty, J. A., Sutton, D. A., Billen, F., . . . Barrs, V. R. (2014). What causes canine sino-nasal aspergillosis? A molecular approach to species identification. Veterinary Journal, 200(1), 17-21.
Scopus18 WoS16 Europe PMC112014 Coad, B., Kidd, S., Ellis, D., & Griesser, H. (2014). Biomaterials surfaces capable of resisting fungal attachment and biofilm formation. Biotechnology Advances, 32(2), 296-307.
Scopus58 WoS54 Europe PMC192013 Chen, S. C. A., Korman, T. M., Slavin, M. A., Marriott, D., Byth, K., Bak, N., . . . Sorrell, T. C. (2013). Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clinical Infectious Diseases, 57(4), 543-551.
Scopus97 WoS85 Europe PMC642013 Barrs, V., van Doorn, T., Houbraken, J., Kidd, S., Martin, P., Pinheiro, M., . . . Samson, R. (2013). Aspergillus felis sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogs. PLoS ONE, 8(6), e64871-1-e64871-11.
Scopus87 WoS77 Europe PMC472013 Holmes, N. E., Trevillyan, J. M., Kidd, S. E., & Leong, T. Y. M. (2013). Locally extensive angio-invasive Scedosporium prolificans infection following resection for squamous cell lung carcinoma. Medical Mycology Case Reports, 2(1), 98-102.
Scopus13 WoS10 Europe PMC82012 Bartlett, K. H., Cheng, P. Y., Duncan, C., Galanis, E., Hoang, L., Kidd, S., . . . Kronstad, J. (2012). A Decade of Experience: Cryptococcus gattii in British Columbia. Mycopathologia, 173(5-6), 311-319.
Scopus60 WoS53 Europe PMC442012 Chen, S. C. A., Slavin, M. A., Heath, C. H., Geoffrey Playford, E., Byth, K., Marriott, D., . . . Sorrell, T. C. (2012). Clinical manifestations of cryptococcus gattii infection: Determinants of neurological sequelae and death. Clinical Infectious Diseases, 55(6), 789-798.
Scopus145 WoS132 Europe PMC982012 Espinel-Ingroff, A., Aller, A., Canton, E., Castanon-Olivares, L., Chowdhary, A., Cordoba, S., . . . Turnidge, J. (2012). Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole. Antimicrobial Agents and Chemotherapy, 56(11), 5898-5906.
Scopus195 WoS188 Europe PMC1402012 Espinel-Ingroff, A., Chowdhary, A., Cuenca-Estrella, M., Fothergill, A., Fuller, J., Hagen, F., . . . Turnidge, J. (2012). Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine. Antimicrobial Agents and Chemotherapy, 56(6), 3107-3113.
Scopus119 WoS111 Europe PMC812011 D'Souza, C. A., Kronstad, J. W., Taylor, G., Warren, R., Yuen, M., Hu, G., . . . Cuomoe, C. A. (2011). Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. mBio, 2(1), 11 pages.
Scopus157 WoS146 Europe PMC1142010 Galanis, E., Macdougall, L., Kidd, S., Morshed, M., & British Columbia Cryptococcus gattii Working Group. (2010). Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007.. Emerging infectious diseases, 16(2), 251-257.
Europe PMC1442010 Galanis, E., & MacDougall, L. (2010). Epidemiology of <i>Cryptococcus gattii</i>, British Columbia, Canada, 1999-2007. EMERGING INFECTIOUS DISEASES, 16(2), 251-257.
WoS1942009 Datta, K., Bartlett, K. H., Baer, R., Byrnes, E., Galanis, E., Heitman, J., . . . Marr, K. A. (2009). Spread of Cryptococcus gattii into Pacific Northwest Region of the United States. EMERGING INFECTIOUS DISEASES, 15(8), 1185-1191.
WoS184 Europe PMC1372009 Datta, K., Bartlett, K. H., Baer, R., Byrnes, E., Galanis, E., Heitman, J., . . . Marr, K. A. (2009). Spread of Cryptococcus gattii into Pacific Northwest Region of the United States. EMERGING INFECTIOUS DISEASES, 15(8), 1185-1191.
WoS184 Europe PMC1372009 Kidd, S. E., Ling, L. M., Meyer, W., Morrissey, C. O., Chen, S. C. A., & Slavin, M. A. (2009). Molecular epidemiology of invasive aspergillosis: Lessons learned from an outbreak investigation in an Australian hematology unit. Infection Control and Hospital Epidemiology, 30(12), 1223-1226.
Scopus13 WoS11 Europe PMC72009 Kidd, S. E., Nik Zulkepeli, N. A. A., Slavin, M. A., & Morrissey, C. O. (2009). Utility of a proposed CSP typing nomenclature for Australian Aspergillus fumigatus isolates: Identification of additional CSP types and suggested modifications. Journal of Microbiological Methods, 78(2), 223-226.
Scopus16 WoS13 Europe PMC102009 Hurst, S. F., Kidd, S. E., Morrissey, C. O., Snelders, E., Melchers, W. J. G., Castelli, M. V., . . . Arunmozhi Balajee, S. (2009). Interlaboratory reproducibility of a single-locus sequence-based method for strain typing of Aspergillus fumigatus. Journal of Clinical Microbiology, 47(5), 1562-1564.
Scopus14 WoS13 Europe PMC82008 Bartlett, K. H., Kidd, S. E., & Kronstad, J. W. (2008). The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest. Current Infectious Disease Reports, 10(1), 58-65.
Scopus85 Europe PMC612007 Upton, A., Fraser, J. A., Kidd, S. E., Bretz, C., Bartlett, K. H., Heitman, J., & Marr, K. A. (2007). First contemporary case of human infection with Cryptococcus gattii in puget sound: Evidence for spread of the Vancouver Island outbreak. Journal of Clinical Microbiology, 45(9), 3086-3088.
Scopus70 WoS64 Europe PMC532007 Kidd, S. E., Bach, P. J., Hingston, A. O., Mak, S., Chow, Y., MacDougall, L., . . . Bartlett, K. H. (2007). Cryptococcus gattii dispersal mechanisms, British Columbia, Canada. Emerging Infectious Diseases, 13(1), 51-57.
Scopus107 WoS98 Europe PMC752007 MacDougall, L., Kidd, S. E., Galanis, E., Mak, S., Leslie, M. J., Cieslak, P. R., . . . Bartlett, K. H. (2007). Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerging Infectious Diseases, 13(1), 42-50.
Scopus232 WoS202 Europe PMC1472007 Kidd, S. E., Chow, Y., Mak, S., Bach, P. J., Chen, H., Hingston, A. O., . . . Bartlett, K. H. (2007). Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States. Applied and Environmental Microbiology, 73(5), 1433-1443.
Scopus186 WoS178 Europe PMC1362006 Filion, T., Kidd, S., & Aguirre, K. (2006). Isolation of Cryptococcus laurentii from Canada Goose guano in rural upstate New York. Mycopathologia, 162(5), 363-368.
Scopus13 WoS12 Europe PMC72005 Kidd, S. E., Guo, H., Bartlett, K. H., Xu, J., & Kronstad, J. W. (2005). Comparative gene genealogies indicate that two clonal lineages of Cryptococcus gattii in British Columbia resemble strains from other geographical areas. Eukaryotic Cell, 4(10), 1629-1638.
Scopus92 WoS95 Europe PMC692004 Kidd, S. E., Hagen, F., Tscharke, R. L., Huynh, M., Bartlett, K. H., Fyfe, M., . . . Meyer, W. (2004). A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proceedings of the National Academy of Sciences of the United States of America, 101(49), 17258-17263.
Scopus608 WoS563 Europe PMC4292004 Igreja, R. P., Dos Santos Lazéra, M., Wanke, B., Gutierrez Galhardo, M. C., Kidd, S. E., & Meyer, W. (2004). Molecular epidemiology of Cryptococcus neoformans isolates from AIDS patients of the Brazilian city, Rio de Janeiro. Medical Mycology, 42(3), 229-238.
Scopus48 WoS47 Europe PMC412004 Katsu, M., Kidd, S., Ando, A., Moretti-Branchini, M. L., Mikami, Y., Nishimura, K., & Meyer, W. (2004). The internal transcribed spacers and 5.8S rRNA gene show extensive diversity among isolates of the Cryptococcus neoformans species complex. FEMS Yeast Research, 4(4-5), 377-388.
Scopus94 WoS97 Europe PMC752003 Kidd, S. E., Sorrell, T. C., & Meyer, W. (2003). Isolation of two molecular types of Cryptococcus neoformans var. gattii from insect frass. Medical Mycology, 41(2), 171-176.
Scopus36 WoS33 Europe PMC20 -
Books
Year Citation 2022 Kidd, S., Halliday, C., & Ellis, D. (2022). Descriptions of Medical Fungi. CABI.
2016 Kidd, S., Halliday, C., Alexiou, H., & Ellis, D. (2016). Descriptions of Medical Fungi Third Edition. -
Book Chapters
Year Citation 2022 Hilmarsdóttir, I., Kidd, S., & Lau, A. (2022). Chapter 87: Mycology. In N. Rifai (Ed.), Tietz Textbook of Laboratory Medicine - E-Book (7th ed.). Elsevier Health Sciences. 2019 Kidd, S. E. (2019). Cryptococcosis. In B. W. Wilcke Jr, & D. L. Heymann (Eds.), Control of Communicable Diseases. American Public Health Association.
2019 Kidd, S. E., & Arthur, I. (2019). Sporotrichosis. In B. W. Wilcke Jr, & D. L. Heymann (Eds.), Control of Communicable Diseases. American Public Health Association.
2018 Halliday, C. L., & Kidd, S. E. (2018). Cryptococcus species. In C. C. Kibbler, R. Barton, N. A. R. Gow, S. Howell, D. M. MacCallum, & R. J. Manuel (Eds.), Oxford Textbook of Medical Mycology (pp. 80-82). Oxford University Press.
2018 Kidd, S. E., & Halliday, C. H. (2018). Dematiaceous fungi. In C. C. Kibbler, R. Barton, N. A. R. Gow, S. Howell, D. M. MacCallum, & R. J. Manuel (Eds.), Oxford Textbook of Medical Mycology (pp. 88-92). UK: Oxford University Press.
- Bartlett, K., Byrnes, E., Duncan, C., Fyfe, M., Galanis, E., Heitman, J., . . . Kronstad, J. (n.d.). The Emergence of <i>Cryptococcus gattii</i> Infections on Vancouver Island and Expansion in the Pacific Northwest. In Cryptococcus (pp. 313-325). ASM Press.
-
Conference Papers
Year Citation 2021 Crawford, L., Turra, M., Kidd, S., & Weldhagen, G. (2021). Candida auris PCR for high throughput infection control screening. In Australasian Society for Infectious Diseases Annual Scientific Meeting. Australia. 2021 Crawford, L., & Kidd, S. (2021). Simple detection and differentiation of Candida auris on CHROMagar Candida Plus agar. In Australasian Society for Infectious Diseases Annual Scientific Meeting. Australia. 2019 Crawford, L. C., Tam, P., Kidd, S., & Nelson, R. (2019). Scopulariopsis gracilis septic arthritis in an immunocompromised host. In Mycology Masterclass. Kingscliff, NSW, Australia. 2016 McGuinness, S., Boyd, R., Kidd, S., McLeod, C., Krause, V., & Ralph, A. (2016). Epidemiological Investigation Of An Outbreak Of Sporotrichosis. In INTERNAL MEDICINE JOURNAL Vol. 46 (pp. 12-13). WILEY-BLACKWELL.
2014 Viiret, E., Birader, M., Holmes, M., Kidd, S., & Holmes-Liew, C. (2014). UTILITY OF BRONCHOALVEOLAR LAVAGE GALACTOMANNAN IN DIAGNOSIS OF ASPERGILLOSIS IN IMMUNOCOMPROMISED PATIENTS. In RESPIROLOGY Vol. 19 (pp. 127). WILEY-BLACKWELL. 2012 Chen, S., Slavin, M., Heath, C., Playford, E. G., Byth, K., Marriott, D., . . . Sorrell, T. (2012). <i>Cryptococcus gattii</i> infection: Long term morbidity and determinants of neurological sequelae and death. In MYCOSES Vol. 55 (pp. 78). WILEY-BLACKWELL. 2007 Galanis, E., MacDougall, L., Li, M., Kidd, S., Lee, M., & Morshed, M. (2007). Clinical and epidemiological aspects of locally-acquired <i>Cryptococcus gattii</i> human infections, an emerging fungal pathogen in British Columbia, Canada. In INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS Vol. 29 (pp. S34-S35). Munich, GERMANY: ELSEVIER SCIENCE BV.
2004 Bartlett, K. H., MacDougall, L., Mak, S., Duncan, C., Kidd, S., & Fyfe, M. (2004). Cryptococcus gattii, a tropical pathogen emerging in a temperate climate zone. In 16th Conference on Biometeorology and Aerobiology (pp. 39-43).
Scopus1 -
Conference Items
Year Citation 2019 Nelson, R., Crawford, L., Kidd, S., & Tam, P. C. K. (2019). Scopulariopsis gracilis septic arthritis. Poster session presented at the meeting of Mycology Master Class. 2017 Espinel-Ingroff, A., Abreu, D. P. B., Almeida-Paes, D., Brilhante, R. S. N., Chakrabarti, A., Chowdhary, A., . . . Turnidge, J. (2017). International evaluation of CLSI MIC/MEC distributions for definition of epidemiological cutoff values (ECVs) for species of Sporothrix identified by molecular methods. Poster session presented at the meeting of MYCOSES. WILEY. 2013 Birader, M. I., Kidd, S., & Holmes-Liew, C. -L. (2013). OPTIMAL UTILITY OF BAL FLUID GALACTOMANNAN IN DIAGNOSING INVASIVE PULMONARY ASPERGILLOSIS IN IMMUNOCOMPROMISED PATIENTS. Poster session presented at the meeting of RESPIROLOGY. WILEY-BLACKWELL. 2013 Birader, M. I., Holmes, M. D., Kidd, S., & Holmes-Liew, C. L. (2013). Utility of bronchoalveolar lavage galactomannan in diagnosis of Aspergillosis in lung transplant recipients. Poster session presented at the meeting of Abstracts from the 33rd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, as published in Journal of Heart and Lung Transplantation. Montreal, Canada: Elsevier.
-
Theses
Year Citation 2003 Kidd, S. (2003). Molecular epidemiology and characterisation of genetic structure to assess speciation within the Cryptococcus neoformans complex. (PhD Thesis, University of Sydney). -
Internet Publications
Year Citation 2014 Kidd, S. E., & ellis, D. (2014). Australian Antifungal Susceptibility Trends in Yeasts: 2000-2013.. Australian Society of Antimicrobials.
-
Committee Memberships
Date Role Committee Institution Country 2019 - 2019 Member ASM Scientific Program Committee, Adelaide, 2019 Australian Society for Microbiology Australia 2012 - 2017 Co-Chair Organising Committee, ISHAM Conference, Melbourne May 4-8 2015 ANZMIG Australia 2011 - ongoing Advisory Board Member RCPA QAP Microbiology Royal College of Pathologists Quality Assurance Program Australia 2011 - ongoing Secretary Australia New Zealand Mycoses Interest Group (ANZMIG) Australasian Society for Infectious Diseases Australia 2011 - 2013 Member ASM Conference Local Organising Committee, Adelaide 2013 ASM Australia 2011 - ongoing Chair Mycology Masterclass (Biennial event) ANZMIG Australia -
Memberships
Date Role Membership Country 2023 - ongoing Member American Society for Microbiology United States 2018 - ongoing Member Australian Society for Antimicrobials Australia 2012 - ongoing Member International Society for Human and Animal Mycology - 2011 - ongoing Member Australasian Society for Infectious Diseases (ASID) Australia 2001 - ongoing Member Australian Society for Microbiology Australia -
Consulting/Advisories
Date Institution Department Organisation Type Country 2018 - ongoing ASA EUCAST National AST Committee (AusNAC) - Scientific research Australia 2017 - ongoing National Association of Testing Authorities - Health services and related Australia 2016 - ongoing International Accreditation New Zealand (IANZ) - Health services and related New Zealand 2015 - ongoing Merck Sharp & Dohme - Health services and related Australia 2014 - ongoing Mayne Pharma - Health services and related Australia 2011 - ongoing Pfizer Anti-infectives - Health services and related Australia -
Editorial Boards
Date Role Editorial Board Name Institution Country 2018 - 2021 Editor Journal of Medical Microbiology Microbiology Society United Kingdom
Connect With Me
External Profiles